nodes	percent_of_prediction	percent_of_DWPC	metapath
Isoprenaline—ADRBK1—blood plasma—systemic lupus erythematosus	0.0122	0.0616	CbGeAlD
Isoprenaline—MAPK1—blood plasma—systemic lupus erythematosus	0.012	0.0607	CbGeAlD
Isoprenaline—PIK3R1—nephron tubule—systemic lupus erythematosus	0.00909	0.0459	CbGeAlD
Isoprenaline—PIK3R2—nervous system—systemic lupus erythematosus	0.00904	0.0457	CbGeAlD
Isoprenaline—PIK3R2—central nervous system—systemic lupus erythematosus	0.0087	0.044	CbGeAlD
Isoprenaline—PIK3R1—cortex of kidney—systemic lupus erythematosus	0.00778	0.0393	CbGeAlD
Isoprenaline—PIK3R3—tendon—systemic lupus erythematosus	0.00755	0.0381	CbGeAlD
Isoprenaline—ADRB3—connective tissue—systemic lupus erythematosus	0.00664	0.0335	CbGeAlD
Isoprenaline—PIK3R3—lung—systemic lupus erythematosus	0.00662	0.0335	CbGeAlD
Isoprenaline—PIK3R1—tendon—systemic lupus erythematosus	0.00645	0.0326	CbGeAlD
Isoprenaline—MAPK1—connective tissue—systemic lupus erythematosus	0.0064	0.0323	CbGeAlD
Isoprenaline—PIK3R1—bone marrow—systemic lupus erythematosus	0.00625	0.0316	CbGeAlD
Isoprenaline—MAPK1—nephron tubule—systemic lupus erythematosus	0.0062	0.0313	CbGeAlD
Isoprenaline—PIK3R3—nervous system—systemic lupus erythematosus	0.00613	0.031	CbGeAlD
Isoprenaline—PIK3R3—central nervous system—systemic lupus erythematosus	0.00591	0.0298	CbGeAlD
Isoprenaline—MAPK1—skin of body—systemic lupus erythematosus	0.00578	0.0292	CbGeAlD
Isoprenaline—PIK3R1—lung—systemic lupus erythematosus	0.00566	0.0286	CbGeAlD
Isoprenaline—ADRBK1—kidney—systemic lupus erythematosus	0.00553	0.0279	CbGeAlD
Isoprenaline—MAPK1—kidney—systemic lupus erythematosus	0.00545	0.0275	CbGeAlD
Isoprenaline—MAPK1—cortex of kidney—systemic lupus erythematosus	0.0053	0.0268	CbGeAlD
Isoprenaline—ADRBK1—lymphoid tissue—systemic lupus erythematosus	0.00475	0.024	CbGeAlD
Isoprenaline—MAPK1—lymphoid tissue—systemic lupus erythematosus	0.00468	0.0236	CbGeAlD
Isoprenaline—ADRBK1—bone marrow—systemic lupus erythematosus	0.00432	0.0218	CbGeAlD
Isoprenaline—MAPK1—bone marrow—systemic lupus erythematosus	0.00426	0.0215	CbGeAlD
Isoprenaline—ADRBK1—lung—systemic lupus erythematosus	0.00392	0.0198	CbGeAlD
Isoprenaline—MAPK1—lung—systemic lupus erythematosus	0.00386	0.0195	CbGeAlD
Isoprenaline—ADRBK1—nervous system—systemic lupus erythematosus	0.00363	0.0183	CbGeAlD
Isoprenaline—MAPK1—nervous system—systemic lupus erythematosus	0.00357	0.0181	CbGeAlD
Isoprenaline—ADRBK1—central nervous system—systemic lupus erythematosus	0.00349	0.0176	CbGeAlD
Isoprenaline—MAPK1—central nervous system—systemic lupus erythematosus	0.00344	0.0174	CbGeAlD
Isoprenaline—Pallor—Leflunomide—systemic lupus erythematosus	0.00294	0.0239	CcSEcCtD
Isoprenaline—ADRB1—connective tissue—systemic lupus erythematosus	0.00272	0.0137	CbGeAlD
Isoprenaline—Pallor—Mycophenolate mofetil—systemic lupus erythematosus	0.00221	0.018	CcSEcCtD
Isoprenaline—Vision blurred—Dapsone—systemic lupus erythematosus	0.00188	0.0153	CcSEcCtD
Isoprenaline—Vertigo—Dapsone—systemic lupus erythematosus	0.00179	0.0146	CcSEcCtD
Isoprenaline—ADRB1—lung—systemic lupus erythematosus	0.00164	0.00827	CbGeAlD
Isoprenaline—Pulmonary oedema—Mycophenolate mofetil—systemic lupus erythematosus	0.00163	0.0133	CcSEcCtD
Isoprenaline—Tachycardia—Dapsone—systemic lupus erythematosus	0.00159	0.0129	CcSEcCtD
Isoprenaline—CYP1A1—skin of body—systemic lupus erythematosus	0.00158	0.00799	CbGeAlD
Isoprenaline—Pulmonary oedema—Prednisolone—systemic lupus erythematosus	0.00152	0.0124	CcSEcCtD
Isoprenaline—ADRB1—nervous system—systemic lupus erythematosus	0.00152	0.00766	CbGeAlD
Isoprenaline—CYP1A1—kidney—systemic lupus erythematosus	0.00149	0.00753	CbGeAlD
Isoprenaline—Angina pectoris—Leflunomide—systemic lupus erythematosus	0.00149	0.0121	CcSEcCtD
Isoprenaline—Pulmonary oedema—Hydrocortisone—systemic lupus erythematosus	0.00149	0.0121	CcSEcCtD
Isoprenaline—Insomnia—Dapsone—systemic lupus erythematosus	0.00147	0.012	CcSEcCtD
Isoprenaline—ADRB1—central nervous system—systemic lupus erythematosus	0.00146	0.00738	CbGeAlD
Isoprenaline—Pulmonary oedema—Triamcinolone—systemic lupus erythematosus	0.0014	0.0114	CcSEcCtD
Isoprenaline—Pulmonary oedema—Methylprednisolone—systemic lupus erythematosus	0.0014	0.0114	CcSEcCtD
Isoprenaline—Pulmonary oedema—Dexamethasone—systemic lupus erythematosus	0.00127	0.0103	CcSEcCtD
Isoprenaline—Pulmonary oedema—Betamethasone—systemic lupus erythematosus	0.00127	0.0103	CcSEcCtD
Isoprenaline—Cardiac arrest—Mycophenolate mofetil—systemic lupus erythematosus	0.00127	0.0103	CcSEcCtD
Isoprenaline—Cardiac arrest—Prednisolone—systemic lupus erythematosus	0.00118	0.0096	CcSEcCtD
Isoprenaline—Bronchospasm—Cyclosporine—systemic lupus erythematosus	0.00116	0.00943	CcSEcCtD
Isoprenaline—Arrhythmia—Azathioprine—systemic lupus erythematosus	0.00116	0.00941	CcSEcCtD
Isoprenaline—Cardiac arrest—Hydrocortisone—systemic lupus erythematosus	0.00115	0.00938	CcSEcCtD
Isoprenaline—Angina pectoris—Mycophenolate mofetil—systemic lupus erythematosus	0.00112	0.00911	CcSEcCtD
Isoprenaline—Pulmonary oedema—Prednisone—systemic lupus erythematosus	0.00111	0.009	CcSEcCtD
Isoprenaline—Arrhythmia—Leflunomide—systemic lupus erythematosus	0.00109	0.00889	CcSEcCtD
Isoprenaline—Cardiac arrest—Triamcinolone—systemic lupus erythematosus	0.00109	0.00883	CcSEcCtD
Isoprenaline—Cardiac arrest—Methylprednisolone—systemic lupus erythematosus	0.00108	0.00881	CcSEcCtD
Isoprenaline—CYP1A1—lung—systemic lupus erythematosus	0.00106	0.00534	CbGeAlD
Isoprenaline—Headache—Dapsone—systemic lupus erythematosus	0.00102	0.00829	CcSEcCtD
Isoprenaline—Vision blurred—Leflunomide—systemic lupus erythematosus	0.001	0.00816	CcSEcCtD
Isoprenaline—Cardiac arrest—Betamethasone—systemic lupus erythematosus	0.000986	0.00801	CcSEcCtD
Isoprenaline—Cardiac arrest—Dexamethasone—systemic lupus erythematosus	0.000986	0.00801	CcSEcCtD
Isoprenaline—Sweating—Mycophenolate mofetil—systemic lupus erythematosus	0.000984	0.008	CcSEcCtD
Isoprenaline—CYP1A1—nervous system—systemic lupus erythematosus	0.000978	0.00494	CbGeAlD
Isoprenaline—Bronchospasm—Methylprednisolone—systemic lupus erythematosus	0.00097	0.00788	CcSEcCtD
Isoprenaline—Nausea—Dapsone—systemic lupus erythematosus	0.000968	0.00786	CcSEcCtD
Isoprenaline—Vertigo—Leflunomide—systemic lupus erythematosus	0.000958	0.00778	CcSEcCtD
Isoprenaline—Palpitations—Leflunomide—systemic lupus erythematosus	0.000942	0.00765	CcSEcCtD
Isoprenaline—CYP1A1—central nervous system—systemic lupus erythematosus	0.000942	0.00476	CbGeAlD
Isoprenaline—Pulmonary oedema—Methotrexate—systemic lupus erythematosus	0.000926	0.00752	CcSEcCtD
Isoprenaline—Hypertension—Leflunomide—systemic lupus erythematosus	0.00092	0.00748	CcSEcCtD
Isoprenaline—Flushing—Cyclosporine—systemic lupus erythematosus	0.000877	0.00712	CcSEcCtD
Isoprenaline—Hypotension—Azathioprine—systemic lupus erythematosus	0.000861	0.00699	CcSEcCtD
Isoprenaline—Cardiac arrest—Prednisone—systemic lupus erythematosus	0.000859	0.00698	CcSEcCtD
Isoprenaline—Tachycardia—Leflunomide—systemic lupus erythematosus	0.000849	0.0069	CcSEcCtD
Isoprenaline—Arrhythmia—Cyclosporine—systemic lupus erythematosus	0.000844	0.00686	CcSEcCtD
Isoprenaline—Sweating—Methylprednisolone—systemic lupus erythematosus	0.000843	0.00684	CcSEcCtD
Isoprenaline—Hyperhidrosis—Leflunomide—systemic lupus erythematosus	0.000841	0.00683	CcSEcCtD
Isoprenaline—Arrhythmia—Mycophenolate mofetil—systemic lupus erythematosus	0.000823	0.00669	CcSEcCtD
Isoprenaline—Hypotension—Leflunomide—systemic lupus erythematosus	0.000813	0.0066	CcSEcCtD
Isoprenaline—Tension—Cyclosporine—systemic lupus erythematosus	0.000807	0.00656	CcSEcCtD
Isoprenaline—Nervousness—Cyclosporine—systemic lupus erythematosus	0.000799	0.00649	CcSEcCtD
Isoprenaline—Tension—Mycophenolate mofetil—systemic lupus erythematosus	0.000787	0.0064	CcSEcCtD
Isoprenaline—Insomnia—Leflunomide—systemic lupus erythematosus	0.000787	0.00639	CcSEcCtD
Isoprenaline—Nervousness—Mycophenolate mofetil—systemic lupus erythematosus	0.000779	0.00633	CcSEcCtD
Isoprenaline—Dyspnoea—Leflunomide—systemic lupus erythematosus	0.000776	0.0063	CcSEcCtD
Isoprenaline—Vision blurred—Cyclosporine—systemic lupus erythematosus	0.000775	0.0063	CcSEcCtD
Isoprenaline—Tremor—Cyclosporine—systemic lupus erythematosus	0.000771	0.00626	CcSEcCtD
Isoprenaline—Arrhythmia—Prednisolone—systemic lupus erythematosus	0.000768	0.00624	CcSEcCtD
Isoprenaline—Tremor—Mycophenolate mofetil—systemic lupus erythematosus	0.000752	0.00611	CcSEcCtD
Isoprenaline—Arrhythmia—Hydrocortisone—systemic lupus erythematosus	0.00075	0.00609	CcSEcCtD
Isoprenaline—Vertigo—Cyclosporine—systemic lupus erythematosus	0.000739	0.006	CcSEcCtD
Isoprenaline—Vertigo—Mycophenolate mofetil—systemic lupus erythematosus	0.000721	0.00586	CcSEcCtD
Isoprenaline—Convulsion—Cyclosporine—systemic lupus erythematosus	0.000713	0.00579	CcSEcCtD
Isoprenaline—Hypertension—Cyclosporine—systemic lupus erythematosus	0.00071	0.00577	CcSEcCtD
Isoprenaline—Palpitations—Mycophenolate mofetil—systemic lupus erythematosus	0.000709	0.00576	CcSEcCtD
Isoprenaline—Arrhythmia—Triamcinolone—systemic lupus erythematosus	0.000706	0.00574	CcSEcCtD
Isoprenaline—Vision blurred—Prednisolone—systemic lupus erythematosus	0.000705	0.00573	CcSEcCtD
Isoprenaline—Arrhythmia—Methylprednisolone—systemic lupus erythematosus	0.000705	0.00573	CcSEcCtD
Isoprenaline—Convulsion—Mycophenolate mofetil—systemic lupus erythematosus	0.000695	0.00565	CcSEcCtD
Isoprenaline—Hypertension—Mycophenolate mofetil—systemic lupus erythematosus	0.000693	0.00563	CcSEcCtD
Isoprenaline—Vertigo—Prednisolone—systemic lupus erythematosus	0.000673	0.00546	CcSEcCtD
Isoprenaline—Vertigo—Hydrocortisone—systemic lupus erythematosus	0.000657	0.00534	CcSEcCtD
Isoprenaline—Hyperhidrosis—Cyclosporine—systemic lupus erythematosus	0.000649	0.00527	CcSEcCtD
Isoprenaline—Convulsion—Prednisolone—systemic lupus erythematosus	0.000649	0.00527	CcSEcCtD
Isoprenaline—Hypertension—Prednisolone—systemic lupus erythematosus	0.000646	0.00525	CcSEcCtD
Isoprenaline—Arrhythmia—Betamethasone—systemic lupus erythematosus	0.000641	0.00521	CcSEcCtD
Isoprenaline—Arrhythmia—Dexamethasone—systemic lupus erythematosus	0.000641	0.00521	CcSEcCtD
Isoprenaline—Tachycardia—Mycophenolate mofetil—systemic lupus erythematosus	0.000639	0.00519	CcSEcCtD
Isoprenaline—Convulsion—Hydrocortisone—systemic lupus erythematosus	0.000633	0.00515	CcSEcCtD
Isoprenaline—Hyperhidrosis—Mycophenolate mofetil—systemic lupus erythematosus	0.000633	0.00514	CcSEcCtD
Isoprenaline—Hypertension—Hydrocortisone—systemic lupus erythematosus	0.000631	0.00513	CcSEcCtD
Isoprenaline—Asthenia—Leflunomide—systemic lupus erythematosus	0.000624	0.00507	CcSEcCtD
Isoprenaline—Vertigo—Triamcinolone—systemic lupus erythematosus	0.000618	0.00502	CcSEcCtD
Isoprenaline—Vertigo—Methylprednisolone—systemic lupus erythematosus	0.000617	0.00501	CcSEcCtD
Isoprenaline—Hypotension—Mycophenolate mofetil—systemic lupus erythematosus	0.000612	0.00497	CcSEcCtD
Isoprenaline—Dizziness—Azathioprine—systemic lupus erythematosus	0.000609	0.00495	CcSEcCtD
Isoprenaline—Insomnia—Cyclosporine—systemic lupus erythematosus	0.000607	0.00493	CcSEcCtD
Isoprenaline—Dyspnoea—Cyclosporine—systemic lupus erythematosus	0.000599	0.00486	CcSEcCtD
Isoprenaline—Convulsion—Triamcinolone—systemic lupus erythematosus	0.000596	0.00484	CcSEcCtD
Isoprenaline—Tachycardia—Prednisolone—systemic lupus erythematosus	0.000596	0.00484	CcSEcCtD
Isoprenaline—Convulsion—Methylprednisolone—systemic lupus erythematosus	0.000595	0.00483	CcSEcCtD
Isoprenaline—Hypertension—Triamcinolone—systemic lupus erythematosus	0.000594	0.00483	CcSEcCtD
Isoprenaline—Hypertension—Methylprednisolone—systemic lupus erythematosus	0.000593	0.00482	CcSEcCtD
Isoprenaline—Insomnia—Mycophenolate mofetil—systemic lupus erythematosus	0.000592	0.00481	CcSEcCtD
Isoprenaline—Hyperhidrosis—Prednisolone—systemic lupus erythematosus	0.000591	0.0048	CcSEcCtD
Isoprenaline—Dyspnoea—Mycophenolate mofetil—systemic lupus erythematosus	0.000584	0.00474	CcSEcCtD
Isoprenaline—Tachycardia—Hydrocortisone—systemic lupus erythematosus	0.000582	0.00473	CcSEcCtD
Isoprenaline—Flushing—Prednisone—systemic lupus erythematosus	0.00058	0.00471	CcSEcCtD
Isoprenaline—Headache—Azathioprine—systemic lupus erythematosus	0.000577	0.00469	CcSEcCtD
Isoprenaline—Hyperhidrosis—Hydrocortisone—systemic lupus erythematosus	0.000577	0.00469	CcSEcCtD
Isoprenaline—Dizziness—Leflunomide—systemic lupus erythematosus	0.000575	0.00467	CcSEcCtD
Isoprenaline—Vertigo—Dexamethasone—systemic lupus erythematosus	0.000561	0.00456	CcSEcCtD
Isoprenaline—Vertigo—Betamethasone—systemic lupus erythematosus	0.000561	0.00456	CcSEcCtD
Isoprenaline—Arrhythmia—Prednisone—systemic lupus erythematosus	0.000558	0.00453	CcSEcCtD
Isoprenaline—Sweating—Methotrexate—systemic lupus erythematosus	0.000558	0.00453	CcSEcCtD
Isoprenaline—Hypotension—Hydrocortisone—systemic lupus erythematosus	0.000558	0.00453	CcSEcCtD
Isoprenaline—Insomnia—Prednisolone—systemic lupus erythematosus	0.000553	0.00449	CcSEcCtD
Isoprenaline—Tachycardia—Triamcinolone—systemic lupus erythematosus	0.000548	0.00445	CcSEcCtD
Isoprenaline—Nausea—Azathioprine—systemic lupus erythematosus	0.000547	0.00444	CcSEcCtD
Isoprenaline—Tachycardia—Methylprednisolone—systemic lupus erythematosus	0.000547	0.00444	CcSEcCtD
Isoprenaline—Headache—Leflunomide—systemic lupus erythematosus	0.000545	0.00443	CcSEcCtD
Isoprenaline—Hyperhidrosis—Triamcinolone—systemic lupus erythematosus	0.000543	0.00441	CcSEcCtD
Isoprenaline—Hyperhidrosis—Methylprednisolone—systemic lupus erythematosus	0.000542	0.0044	CcSEcCtD
Isoprenaline—Convulsion—Dexamethasone—systemic lupus erythematosus	0.000541	0.0044	CcSEcCtD
Isoprenaline—Convulsion—Betamethasone—systemic lupus erythematosus	0.000541	0.0044	CcSEcCtD
Isoprenaline—Insomnia—Hydrocortisone—systemic lupus erythematosus	0.00054	0.00438	CcSEcCtD
Isoprenaline—Hypertension—Betamethasone—systemic lupus erythematosus	0.000539	0.00438	CcSEcCtD
Isoprenaline—Hypertension—Dexamethasone—systemic lupus erythematosus	0.000539	0.00438	CcSEcCtD
Isoprenaline—Hypotension—Methylprednisolone—systemic lupus erythematosus	0.000524	0.00426	CcSEcCtD
Isoprenaline—Nausea—Leflunomide—systemic lupus erythematosus	0.000517	0.0042	CcSEcCtD
Isoprenaline—Vision blurred—Prednisone—systemic lupus erythematosus	0.000513	0.00416	CcSEcCtD
Isoprenaline—Insomnia—Triamcinolone—systemic lupus erythematosus	0.000508	0.00413	CcSEcCtD
Isoprenaline—Insomnia—Methylprednisolone—systemic lupus erythematosus	0.000507	0.00412	CcSEcCtD
Isoprenaline—Dyspnoea—Triamcinolone—systemic lupus erythematosus	0.000501	0.00407	CcSEcCtD
Isoprenaline—Tachycardia—Dexamethasone—systemic lupus erythematosus	0.000497	0.00404	CcSEcCtD
Isoprenaline—Tachycardia—Betamethasone—systemic lupus erythematosus	0.000497	0.00404	CcSEcCtD
Isoprenaline—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	0.000493	0.004	CcSEcCtD
Isoprenaline—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	0.000493	0.004	CcSEcCtD
Isoprenaline—Vertigo—Prednisone—systemic lupus erythematosus	0.000489	0.00397	CcSEcCtD
Isoprenaline—Asthenia—Cyclosporine—systemic lupus erythematosus	0.000482	0.00391	CcSEcCtD
Isoprenaline—Hypotension—Betamethasone—systemic lupus erythematosus	0.000476	0.00387	CcSEcCtD
Isoprenaline—Hypotension—Dexamethasone—systemic lupus erythematosus	0.000476	0.00387	CcSEcCtD
Isoprenaline—Convulsion—Prednisone—systemic lupus erythematosus	0.000471	0.00383	CcSEcCtD
Isoprenaline—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	0.00047	0.00382	CcSEcCtD
Isoprenaline—Hypertension—Prednisone—systemic lupus erythematosus	0.00047	0.00381	CcSEcCtD
Isoprenaline—Insomnia—Dexamethasone—systemic lupus erythematosus	0.000461	0.00375	CcSEcCtD
Isoprenaline—Insomnia—Betamethasone—systemic lupus erythematosus	0.000461	0.00375	CcSEcCtD
Isoprenaline—Dizziness—Cyclosporine—systemic lupus erythematosus	0.000444	0.00361	CcSEcCtD
Isoprenaline—Tachycardia—Prednisone—systemic lupus erythematosus	0.000433	0.00352	CcSEcCtD
Isoprenaline—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	0.000433	0.00352	CcSEcCtD
Isoprenaline—Hyperhidrosis—Prednisone—systemic lupus erythematosus	0.000429	0.00349	CcSEcCtD
Isoprenaline—Vision blurred—Methotrexate—systemic lupus erythematosus	0.000428	0.00348	CcSEcCtD
Isoprenaline—Asthenia—Hydrocortisone—systemic lupus erythematosus	0.000428	0.00348	CcSEcCtD
Isoprenaline—Headache—Cyclosporine—systemic lupus erythematosus	0.000421	0.00342	CcSEcCtD
Isoprenaline—Headache—Mycophenolate mofetil—systemic lupus erythematosus	0.00041	0.00333	CcSEcCtD
Isoprenaline—Vertigo—Methotrexate—systemic lupus erythematosus	0.000408	0.00332	CcSEcCtD
Isoprenaline—Dizziness—Prednisolone—systemic lupus erythematosus	0.000404	0.00328	CcSEcCtD
Isoprenaline—Asthenia—Triamcinolone—systemic lupus erythematosus	0.000403	0.00327	CcSEcCtD
Isoprenaline—Asthenia—Methylprednisolone—systemic lupus erythematosus	0.000402	0.00327	CcSEcCtD
Isoprenaline—Insomnia—Prednisone—systemic lupus erythematosus	0.000402	0.00326	CcSEcCtD
Isoprenaline—Nausea—Cyclosporine—systemic lupus erythematosus	0.000399	0.00324	CcSEcCtD
Isoprenaline—Dizziness—Hydrocortisone—systemic lupus erythematosus	0.000395	0.00321	CcSEcCtD
Isoprenaline—Convulsion—Methotrexate—systemic lupus erythematosus	0.000394	0.0032	CcSEcCtD
Isoprenaline—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	0.000389	0.00316	CcSEcCtD
Isoprenaline—Headache—Prednisolone—systemic lupus erythematosus	0.000383	0.00311	CcSEcCtD
Isoprenaline—Headache—Hydrocortisone—systemic lupus erythematosus	0.000374	0.00304	CcSEcCtD
Isoprenaline—Dizziness—Triamcinolone—systemic lupus erythematosus	0.000371	0.00302	CcSEcCtD
Isoprenaline—Dizziness—Methylprednisolone—systemic lupus erythematosus	0.000371	0.00301	CcSEcCtD
Isoprenaline—Asthenia—Dexamethasone—systemic lupus erythematosus	0.000366	0.00297	CcSEcCtD
Isoprenaline—Asthenia—Betamethasone—systemic lupus erythematosus	0.000366	0.00297	CcSEcCtD
Isoprenaline—Nausea—Prednisolone—systemic lupus erythematosus	0.000363	0.00295	CcSEcCtD
Isoprenaline—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	0.000359	0.00291	CcSEcCtD
Isoprenaline—Nausea—Hydrocortisone—systemic lupus erythematosus	0.000354	0.00288	CcSEcCtD
Isoprenaline—Headache—Triamcinolone—systemic lupus erythematosus	0.000352	0.00286	CcSEcCtD
Isoprenaline—Headache—Methylprednisolone—systemic lupus erythematosus	0.000351	0.00285	CcSEcCtD
Isoprenaline—Hypotension—Methotrexate—systemic lupus erythematosus	0.000347	0.00282	CcSEcCtD
Isoprenaline—Dizziness—Dexamethasone—systemic lupus erythematosus	0.000337	0.00274	CcSEcCtD
Isoprenaline—Dizziness—Betamethasone—systemic lupus erythematosus	0.000337	0.00274	CcSEcCtD
Isoprenaline—Insomnia—Methotrexate—systemic lupus erythematosus	0.000336	0.00273	CcSEcCtD
Isoprenaline—Nausea—Triamcinolone—systemic lupus erythematosus	0.000334	0.00271	CcSEcCtD
Isoprenaline—Nausea—Methylprednisolone—systemic lupus erythematosus	0.000333	0.0027	CcSEcCtD
Isoprenaline—Dyspnoea—Methotrexate—systemic lupus erythematosus	0.000331	0.00269	CcSEcCtD
Isoprenaline—Headache—Dexamethasone—systemic lupus erythematosus	0.000319	0.00259	CcSEcCtD
Isoprenaline—Headache—Betamethasone—systemic lupus erythematosus	0.000319	0.00259	CcSEcCtD
Isoprenaline—Asthenia—Prednisone—systemic lupus erythematosus	0.000318	0.00259	CcSEcCtD
Isoprenaline—Nausea—Dexamethasone—systemic lupus erythematosus	0.000303	0.00246	CcSEcCtD
Isoprenaline—Nausea—Betamethasone—systemic lupus erythematosus	0.000303	0.00246	CcSEcCtD
Isoprenaline—Dizziness—Prednisone—systemic lupus erythematosus	0.000294	0.00238	CcSEcCtD
Isoprenaline—Headache—Prednisone—systemic lupus erythematosus	0.000278	0.00226	CcSEcCtD
Isoprenaline—Asthenia—Methotrexate—systemic lupus erythematosus	0.000266	0.00216	CcSEcCtD
Isoprenaline—Nausea—Prednisone—systemic lupus erythematosus	0.000264	0.00214	CcSEcCtD
Isoprenaline—Dizziness—Methotrexate—systemic lupus erythematosus	0.000245	0.00199	CcSEcCtD
Isoprenaline—Headache—Methotrexate—systemic lupus erythematosus	0.000232	0.00189	CcSEcCtD
Isoprenaline—Nausea—Methotrexate—systemic lupus erythematosus	0.00022	0.00179	CcSEcCtD
Isoprenaline—ADRBK1—Disease—CDKN1B—systemic lupus erythematosus	2.18e-05	3.21e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—CDKN1A—systemic lupus erythematosus	2.18e-05	3.21e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—JAK1—systemic lupus erythematosus	2.18e-05	3.21e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—CD80—systemic lupus erythematosus	2.16e-05	3.18e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—JAK1—systemic lupus erythematosus	2.15e-05	3.17e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—NAT2—systemic lupus erythematosus	2.15e-05	3.16e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—SH2B3—systemic lupus erythematosus	2.14e-05	3.16e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Metabolism—NOS3—systemic lupus erythematosus	2.14e-05	3.15e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—IFNG—systemic lupus erythematosus	2.14e-05	3.15e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—VEGFA—systemic lupus erythematosus	2.13e-05	3.14e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—CD80—systemic lupus erythematosus	2.13e-05	3.13e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—CCR5—systemic lupus erythematosus	2.13e-05	3.13e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—TGFB1—systemic lupus erythematosus	2.12e-05	3.12e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CXCL12—systemic lupus erythematosus	2.11e-05	3.11e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—TYK2—systemic lupus erythematosus	2.11e-05	3.1e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—EP300—systemic lupus erythematosus	2.1e-05	3.1e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—F2—systemic lupus erythematosus	2.1e-05	3.09e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—IL2RA—systemic lupus erythematosus	2.1e-05	3.09e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Hemostasis—VEGFA—systemic lupus erythematosus	2.09e-05	3.08e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—CDKN1A—systemic lupus erythematosus	2.09e-05	3.08e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Cell Cycle—EP300—systemic lupus erythematosus	2.09e-05	3.07e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—CCR5—systemic lupus erythematosus	2.08e-05	3.07e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—IL2—systemic lupus erythematosus	2.08e-05	3.06e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—CRP—systemic lupus erythematosus	2.08e-05	3.06e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—C3—systemic lupus erythematosus	2.08e-05	3.06e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—CCR5—systemic lupus erythematosus	2.07e-05	3.06e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—EP300—systemic lupus erythematosus	2.07e-05	3.05e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—JUNB—systemic lupus erythematosus	2.07e-05	3.05e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—NOS3—systemic lupus erythematosus	2.07e-05	3.05e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Axon guidance—IL6—systemic lupus erythematosus	2.07e-05	3.05e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—CD4—systemic lupus erythematosus	2.06e-05	3.04e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—CCR5—systemic lupus erythematosus	2.06e-05	3.04e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—IL2RA—systemic lupus erythematosus	2.05e-05	3.03e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—IL2RA—systemic lupus erythematosus	2.04e-05	3.01e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—CDKN1A—systemic lupus erythematosus	2.04e-05	3.01e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Metabolism—EP300—systemic lupus erythematosus	2.04e-05	3.01e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—CCR5—systemic lupus erythematosus	2.04e-05	3e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—C3—systemic lupus erythematosus	2.04e-05	3e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—IL2—systemic lupus erythematosus	2.03e-05	2.99e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—C3—systemic lupus erythematosus	2.03e-05	2.99e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—PPARG—systemic lupus erythematosus	2.01e-05	2.97e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—CDKN1A—systemic lupus erythematosus	2.01e-05	2.96e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—IL2RA—systemic lupus erythematosus	2.01e-05	2.96e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—CCL2—systemic lupus erythematosus	2.01e-05	2.96e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—C3—systemic lupus erythematosus	1.99e-05	2.94e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—TLR4—systemic lupus erythematosus	1.99e-05	2.93e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—HLA-DRB1—systemic lupus erythematosus	1.99e-05	2.93e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—EP300—systemic lupus erythematosus	1.99e-05	2.93e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—CCL2—systemic lupus erythematosus	1.98e-05	2.91e-05	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—F2—systemic lupus erythematosus	1.97e-05	2.9e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—RASGRP1—systemic lupus erythematosus	1.97e-05	2.9e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—TGFB1—systemic lupus erythematosus	1.96e-05	2.88e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Metabolism—PTGS2—systemic lupus erythematosus	1.96e-05	2.88e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.94e-05	2.86e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—EP300—systemic lupus erythematosus	1.94e-05	2.86e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—CDKN1B—systemic lupus erythematosus	1.94e-05	2.86e-05	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—F2—systemic lupus erythematosus	1.93e-05	2.84e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Hemostasis—TGFB1—systemic lupus erythematosus	1.92e-05	2.83e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Innate Immune System—IL6—systemic lupus erythematosus	1.92e-05	2.82e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—EP300—systemic lupus erythematosus	1.91e-05	2.82e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—PRL—systemic lupus erythematosus	1.91e-05	2.81e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—CD4—systemic lupus erythematosus	1.91e-05	2.81e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—IL2—systemic lupus erythematosus	1.9e-05	2.8e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—IL2—systemic lupus erythematosus	1.9e-05	2.8e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—PTGS2—systemic lupus erythematosus	1.89e-05	2.79e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling by GPCR—IL6—systemic lupus erythematosus	1.89e-05	2.79e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—CCL2—systemic lupus erythematosus	1.87e-05	2.76e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—CD80—systemic lupus erythematosus	1.84e-05	2.71e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—TNF—systemic lupus erythematosus	1.83e-05	2.69e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—F2—systemic lupus erythematosus	1.82e-05	2.69e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—TYK2—systemic lupus erythematosus	1.82e-05	2.68e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—ALB—systemic lupus erythematosus	1.81e-05	2.67e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—MMP9—systemic lupus erythematosus	1.8e-05	2.65e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CXCL12—systemic lupus erythematosus	1.8e-05	2.65e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—TYK2—systemic lupus erythematosus	1.79e-05	2.64e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.79e-05	2.64e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—CDKN1B—systemic lupus erythematosus	1.79e-05	2.64e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—CDKN1A—systemic lupus erythematosus	1.79e-05	2.64e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—F2—systemic lupus erythematosus	1.79e-05	2.63e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—NOS3—systemic lupus erythematosus	1.79e-05	2.63e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—F2—systemic lupus erythematosus	1.78e-05	2.62e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—JUNB—systemic lupus erythematosus	1.76e-05	2.6e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—NOS3—systemic lupus erythematosus	1.76e-05	2.59e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CXCL12—systemic lupus erythematosus	1.76e-05	2.59e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—F2—systemic lupus erythematosus	1.75e-05	2.58e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—CD80—systemic lupus erythematosus	1.75e-05	2.58e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—NOS3—systemic lupus erythematosus	1.73e-05	2.55e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—IL6—systemic lupus erythematosus	1.73e-05	2.55e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—JUNB—systemic lupus erythematosus	1.73e-05	2.54e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—CD80—systemic lupus erythematosus	1.71e-05	2.51e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—EP300—systemic lupus erythematosus	1.71e-05	2.51e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.71e-05	2.51e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—EP300—systemic lupus erythematosus	1.7e-05	2.51e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—TYK2—systemic lupus erythematosus	1.7e-05	2.5e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—CD80—systemic lupus erythematosus	1.7e-05	2.5e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—TGFB1—systemic lupus erythematosus	1.69e-05	2.49e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—RASGRP1—systemic lupus erythematosus	1.68e-05	2.47e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—TGFB1—systemic lupus erythematosus	1.66e-05	2.45e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—CDKN1A—systemic lupus erythematosus	1.65e-05	2.44e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—RASGRP1—systemic lupus erythematosus	1.64e-05	2.41e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Metabolism—EP300—systemic lupus erythematosus	1.63e-05	2.4e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—CCL2—systemic lupus erythematosus	1.63e-05	2.39e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—PRL—systemic lupus erythematosus	1.62e-05	2.39e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.62e-05	2.38e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—IL6—systemic lupus erythematosus	1.6e-05	2.35e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—CCL2—systemic lupus erythematosus	1.59e-05	2.35e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—PRL—systemic lupus erythematosus	1.59e-05	2.34e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—CCL2—systemic lupus erythematosus	1.59e-05	2.34e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—PTGS2—systemic lupus erythematosus	1.58e-05	2.33e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—EP300—systemic lupus erythematosus	1.57e-05	2.32e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—CCL2—systemic lupus erythematosus	1.56e-05	2.3e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—TYK2—systemic lupus erythematosus	1.55e-05	2.29e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.55e-05	2.28e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.53e-05	2.26e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.53e-05	2.25e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—JAK1—systemic lupus erythematosus	1.52e-05	2.25e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—IL2—systemic lupus erythematosus	1.52e-05	2.23e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by GPCR—IL6—systemic lupus erythematosus	1.51e-05	2.22e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—IL2—systemic lupus erythematosus	1.49e-05	2.2e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by GPCR—IL6—systemic lupus erythematosus	1.49e-05	2.19e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.48e-05	2.18e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—TYK2—systemic lupus erythematosus	1.48e-05	2.17e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—IL6—systemic lupus erythematosus	1.48e-05	2.17e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—IFNG—systemic lupus erythematosus	1.45e-05	2.14e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—NOS3—systemic lupus erythematosus	1.45e-05	2.13e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—TYK2—systemic lupus erythematosus	1.45e-05	2.13e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CCR5—systemic lupus erythematosus	1.44e-05	2.13e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—TYK2—systemic lupus erythematosus	1.44e-05	2.12e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—MMP9—systemic lupus erythematosus	1.43e-05	2.11e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—TYK2—systemic lupus erythematosus	1.43e-05	2.11e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.43e-05	2.11e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—IL2RA—systemic lupus erythematosus	1.42e-05	2.1e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—TYK2—systemic lupus erythematosus	1.42e-05	2.09e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—NOS3—systemic lupus erythematosus	1.41e-05	2.08e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—IL2—systemic lupus erythematosus	1.41e-05	2.08e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—MMP9—systemic lupus erythematosus	1.41e-05	2.08e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—C3—systemic lupus erythematosus	1.41e-05	2.08e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.41e-05	2.07e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—NOS3—systemic lupus erythematosus	1.41e-05	2.07e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—CD4—systemic lupus erythematosus	1.4e-05	2.07e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—IL6—systemic lupus erythematosus	1.38e-05	2.03e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—TGFB1—systemic lupus erythematosus	1.37e-05	2.02e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—EP300—systemic lupus erythematosus	1.36e-05	2e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—IL6—systemic lupus erythematosus	1.36e-05	2e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	1.34e-05	1.98e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—EP300—systemic lupus erythematosus	1.34e-05	1.97e-05	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—IL2—systemic lupus erythematosus	1.33e-05	1.95e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—CDKN1B—systemic lupus erythematosus	1.32e-05	1.94e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—EP300—systemic lupus erythematosus	1.32e-05	1.94e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—IL6—systemic lupus erythematosus	1.3e-05	1.92e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—JAK1—systemic lupus erythematosus	1.3e-05	1.91e-05	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—IL2—systemic lupus erythematosus	1.3e-05	1.91e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—CD4—systemic lupus erythematosus	1.3e-05	1.91e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—IL2—systemic lupus erythematosus	1.29e-05	1.9e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.29e-05	1.9e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—PTGS2—systemic lupus erythematosus	1.29e-05	1.89e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—IL6—systemic lupus erythematosus	1.27e-05	1.87e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—JAK1—systemic lupus erythematosus	1.27e-05	1.87e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.27e-05	1.87e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.26e-05	1.85e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—IL6—systemic lupus erythematosus	1.25e-05	1.85e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—F2—systemic lupus erythematosus	1.24e-05	1.83e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CCR5—systemic lupus erythematosus	1.23e-05	1.81e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—IL2—systemic lupus erythematosus	1.23e-05	1.81e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.23e-05	1.8e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—IL6—systemic lupus erythematosus	1.22e-05	1.8e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—CDKN1B—systemic lupus erythematosus	1.22e-05	1.79e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—CDKN1A—systemic lupus erythematosus	1.22e-05	1.79e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—IL2RA—systemic lupus erythematosus	1.21e-05	1.79e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CCR5—systemic lupus erythematosus	1.2e-05	1.77e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—IL2—systemic lupus erythematosus	1.2e-05	1.77e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—C3—systemic lupus erythematosus	1.2e-05	1.77e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—RXRA—systemic lupus erythematosus	1.2e-05	1.77e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—IL2—systemic lupus erythematosus	1.2e-05	1.77e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—IL6—systemic lupus erythematosus	1.19e-05	1.76e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CD80—systemic lupus erythematosus	1.19e-05	1.75e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—IL2RA—systemic lupus erythematosus	1.19e-05	1.75e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.18e-05	1.74e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—IL2—systemic lupus erythematosus	1.18e-05	1.74e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—C3—systemic lupus erythematosus	1.18e-05	1.73e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.16e-05	1.72e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—MMP9—systemic lupus erythematosus	1.16e-05	1.71e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—EP300—systemic lupus erythematosus	1.16e-05	1.71e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.16e-05	1.71e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—MMP9—systemic lupus erythematosus	1.13e-05	1.67e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.13e-05	1.67e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—CDKN1A—systemic lupus erythematosus	1.12e-05	1.66e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—IL6—systemic lupus erythematosus	1.12e-05	1.65e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—IL6—systemic lupus erythematosus	1.12e-05	1.64e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.12e-05	1.64e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CCL2—systemic lupus erythematosus	1.1e-05	1.63e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—EP300—systemic lupus erythematosus	1.1e-05	1.62e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—EP300—systemic lupus erythematosus	1.08e-05	1.58e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—EP300—systemic lupus erythematosus	1.07e-05	1.58e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—F2—systemic lupus erythematosus	1.06e-05	1.56e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.04e-05	1.54e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—F2—systemic lupus erythematosus	1.03e-05	1.52e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—IL6—systemic lupus erythematosus	1.03e-05	1.52e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.02e-05	1.5e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CD80—systemic lupus erythematosus	1.01e-05	1.49e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—TYK2—systemic lupus erythematosus	1e-05	1.48e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CD80—systemic lupus erythematosus	9.91e-06	1.46e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—NOS3—systemic lupus erythematosus	9.85e-06	1.45e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—TGFB1—systemic lupus erythematosus	9.58e-06	1.41e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CCL2—systemic lupus erythematosus	9.42e-06	1.39e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—TGFB1—systemic lupus erythematosus	9.35e-06	1.38e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—TGFB1—systemic lupus erythematosus	9.3e-06	1.37e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CCL2—systemic lupus erythematosus	9.21e-06	1.36e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—IL6—systemic lupus erythematosus	8.91e-06	1.31e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—IL6—systemic lupus erythematosus	8.78e-06	1.29e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—TYK2—systemic lupus erythematosus	8.55e-06	1.26e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	8.53e-06	1.26e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—NOS3—systemic lupus erythematosus	8.39e-06	1.24e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—TYK2—systemic lupus erythematosus	8.37e-06	1.23e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—IL2—systemic lupus erythematosus	8.35e-06	1.23e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—IL6—systemic lupus erythematosus	8.31e-06	1.22e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—NOS3—systemic lupus erythematosus	8.21e-06	1.21e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—MMP9—systemic lupus erythematosus	7.9e-06	1.16e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	7.87e-06	1.16e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—PPARG—systemic lupus erythematosus	7.6e-06	1.12e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—IL6—systemic lupus erythematosus	7.59e-06	1.12e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—EP300—systemic lupus erythematosus	7.49e-06	1.1e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	7.27e-06	1.07e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—IL6—systemic lupus erythematosus	7.22e-06	1.06e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—IL2—systemic lupus erythematosus	7.12e-06	1.05e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CDKN1B—systemic lupus erythematosus	7.11e-06	1.05e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—VEGFA—systemic lupus erythematosus	7.1e-06	1.05e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—IL6—systemic lupus erythematosus	7.08e-06	1.04e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—IL6—systemic lupus erythematosus	7.05e-06	1.04e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—IL6—systemic lupus erythematosus	7.01e-06	1.03e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—IL2—systemic lupus erythematosus	6.96e-06	1.03e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—IL6—systemic lupus erythematosus	6.93e-06	1.02e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—ALB—systemic lupus erythematosus	6.83e-06	1.01e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—MMP9—systemic lupus erythematosus	6.73e-06	9.92e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	6.71e-06	9.88e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—MMP9—systemic lupus erythematosus	6.59e-06	9.7e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CDKN1A—systemic lupus erythematosus	6.56e-06	9.67e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—NOS3—systemic lupus erythematosus	6.53e-06	9.62e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—TGFB1—systemic lupus erythematosus	6.51e-06	9.59e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—EP300—systemic lupus erythematosus	6.38e-06	9.4e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—EP300—systemic lupus erythematosus	6.25e-06	9.2e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—VEGFA—systemic lupus erythematosus	6.05e-06	8.91e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—PTGS2—systemic lupus erythematosus	5.98e-06	8.8e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—VEGFA—systemic lupus erythematosus	5.92e-06	8.71e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—TGFB1—systemic lupus erythematosus	5.55e-06	8.17e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—TGFB1—systemic lupus erythematosus	5.43e-06	8e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—EP300—systemic lupus erythematosus	4.97e-06	7.32e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—IL6—systemic lupus erythematosus	4.91e-06	7.23e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—IL6—systemic lupus erythematosus	4.18e-06	6.16e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—IL6—systemic lupus erythematosus	4.09e-06	6.03e-06	CbGpPWpGaD
